Why the study?
Does electrophysiologically guided antiarrhythmic therapy with implantable defibrillators reduce sudden death in high-risk patients with coronary disease?
Does electrophysiologically guided antiarrhythmic therapy with implantable defibrillators reduce sudden death in high-risk patients with coronary disease?
Implantable defibrillators are effective in reducing sudden death in high-risk coronary disease patients, outperforming antiarrhythmic drugs.
Supports ICD use over drugs for sudden death prevention in high-risk CAD; confirms electrophysiologic guidance benefit in RCTs.
Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.
No takes yet. Share an insight, caveat, or question.
Buxton et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: